Cross Country Healthcare (CCRN) Tops Q2 EPS by 8c; Offers Q3 Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
Tweet
Share
E-mailGet Alerts CCRN Hot Sheet
Join SI Premium – FREE
Cross Country Healthcare (NASDAQ: CCRN) reported Q2 EPS of $0.69, $0.08 better than the analyst estimate of $0.61. Revenue for the quarter came in at $540.7 million versus the consensus estimate of $531.7 million.
GUIDANCE:
Cross Country Healthcare sees Q3 2023 EPS of $0.35-$0.45, versus the consensus of $0.50. Cross Country Healthcare sees Q3 2023 revenue of $440-450 million, versus the consensus of $465 million.
For earnings history and earnings-related data on Cross Country Healthcare (CCRN) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Chime Financial, Inc. (CHYM) Tops Q3 EPS by 13c ; Offers Guidance
- Traeger, Inc. (COOK) Misses Q3 EPS by 223c
- MKS Instruments (MKSI) Tops Q3 EPS by 55c, Beats on Revenue; Offers Q4 Guidance
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
